Table 1.
Functions | References | |
---|---|---|
ECM components | ||
Collagen | Promotes survival in β-cell lines and primary islets, both with or without encapsulation | (17–23) |
Laminin | Promotes proliferation in primary human islets and β-cell lines; increases survival of primary mouse islets and β-cell lines | (19, 24, 25) |
Fibronectin | Increases proliferation in rat islets; increases viability and decreases apoptosis in MIN6 β-cell line | (19, 21) |
Heparan sulfate proteoglycans | Loss decreases β-cell proliferation and increases β-cell apoptosis; protects β-cells from reactive oxygen species-induced apoptosis | (26, 27) |
Matricellular proteins and growth factors | ||
CCN2 | Overexpression during embryogenesis induces β-cell proliferation; promotes β-cell proliferation of mouse islets ex vivo and in vivo after β-cell injury; loss disrupts compensatory β-cell mass increase during pregnancy | (28, 29) |
FGF | Loss decreases β-cell number; protects against β-cell death during lipo- and glucotoxicity | (30, 31) |
VEGF | Loss decreases β-cell proliferation; overexpression using the Pdx1 promoter increases β-cell proliferation and survival; overexpression using the RIP leads to β-cell loss | (10, 32–35) |
HGF | Inactivation during embryogenesis results in decreased pancreatic insulin content; inactivation during pregnancy reduces maternal β-cell compensation and increases β-cell apoptosis; treatment increases β-cell survival after toxin exposure; inactivation decreases β-cell regeneration after injury | (36–38) |
Abbreviations: MIN6, mouse insulin-secreting cell line; RIP, rat insulin promoter.